Significance of cell-free epstein-barr virus DNA in monitoring prognosis of nasopharyngeal carcinoma
- 7 Downloads
It has been reported that cell-free Epstein-Barr virus (EBV-DNA) in plasma was useful in diagnosing and monitoring nasopharyngeal carcinoma (NPC). The current study was designed to evaluate the significance of EBV-DNA in monitoring the prognosis of nasopharyngeal carcinoma and comparing its significance with that of plasma VCA/lgA and EA/lgA levels.
E8V -DNA, VCA/lgA, and EA/lgA levels in plasma were determined in NPC patients with different prognosis after radiotherapy, including 30 distant metastatic patients, 22 local recurrence patients and 24 individuals with remission who had been followed-up for more than 2 years after treatment. EBV-DNA was determined using a real-time quantitative PCR system, and levels of VCA/lgA and EA/lgA were measured using standard immunofluorescence. In a cohort study, the indexes were determined after different radiation periods for the 20 new cases of nasopharyngeal carcinoma.
The median plasma EBV-DNA concentration was 135,100 copies/ ml (interquartile range: 5,525-1,003 750) in metastatic group, 20,500 copies/ ml (interquartile range: 0 -58,500) in the local recurrence group and 0 copies/ml (interquartile range: 0-0) in the continuous remission group (P< 0.05). The levels of VCA/lgA and EA/lgA showed no significant differences among the different groups. The high level of EBV-DNA concentration in the metastatic group was more than that in the local recurrence group. A level of 1,000,000 copies/ml of EBV DNA was an indication of distant metastasis of the NPC patients with a sensitivity of 27.3%. However, the sensitivity was 0 in the local recurrence group. For the 20 new patients, EBV -DNA concentration gradually decreased during the radiation period. Before radiation there were 32,050 copies/ml (interquartile range: 3,880-317,750), 0 copies/ml (interquartile range: 0-14 375) after a 40 Gy radiation dose and 0 copies/ml (interquartile range: 0-2940) after the radiation was finished (P< 0.05). However, the levels of VCA/lgA and EA/lgA showed no significant difference.
Determination of plasma cell -free EBV -DNA level is more valuable than evaluation of VCA/lgA and EA/lgA for monitoring the prognosis of NPC patients.
Keywordsnasopharyngeal carcinoma (NPC) DNA Epstein-Barr virus (EBV) polymerase chain reaction (PCR) prognosis
Unable to display preview. Download preview PDF.
- 1.Min HQ. Nasopharyngeal Carcinoma. Li SL, Chief editor. Head & Neck Carcinoma. Tianjin: Tianjin Science & Technology Press. 1993:536–606.Google Scholar
- 3.Hong MH, Fang JQ, Ma J, et al. Using FLF and FDM for prognostic study of nasopharyngeal carcinoma — with 411 cases of nasopharyngeal carcinoma analysis. Chin J Cancer. 1998;17: 118.Google Scholar
- 8.Cao SM, Gao JS, Liu XD, et al. Significance of plasma EBV-DNA detected by real-time quantitative PCR in diagnosing nasopharyngeal carcinoma. Chin J Cancer. 2002;2l: 328–329.Google Scholar
- 10.Liu YX. Detection of VCA/IgA antibody in nasopharyngeal carcinoma patients by immunolluorescence. Chin J Oncol. 1979 1:118.Google Scholar
- 11.Fang JQ. Design and analysis in diagnosing and screening. Fang JQ, Chief Editor. Medical Statistics & Computer Experiment. Shanghai: Shanghai Science & Technology Press. 1995: 224.Google Scholar
- 12.Liu MZ, Guan XX, Gao JM, et al. Relationship between EB virus VCA-IgA antibody and long-term cure of nasopharyngeal carcinoma. Chin J Cancer. 1998;17:365–367.Google Scholar
- 14.Sam CK, Abu-Samah AJ, Prasad U. IgA/VCA as a followup marker in the monitoring of imopharyngeai carcinoma. Eur J Surg Oneol.1994;20:561–564.Google Scholar
- 15.Peng PJ, Zhao C, Zhang L, et al. Relationship between the kinetics of plasma EBV-DNA levels and clinical response during treatment in patients with nasopharyngeal carcinoma. Chin J Cancer. 2002;21: 817–824.Google Scholar